0001562180-16-003298.txt : 20161031 0001562180-16-003298.hdr.sgml : 20161031 20161031191523 ACCESSION NUMBER: 0001562180-16-003298 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161027 FILED AS OF DATE: 20161031 DATE AS OF CHANGE: 20161031 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC CENTRAL INDEX KEY: 0001100412 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841460811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 3033816600 MAIL ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Orwin John A CENTRAL INDEX KEY: 0001477384 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16633 FILM NUMBER: 161962917 MAIL ADDRESS: STREET 1: C/O RELYPSA, INC. STREET 2: 700 SAGINAW DR. CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2016-10-27 false 0001100412 ARRAY BIOPHARMA INC ARRY 0001477384 Orwin John A C/O RELYPSA, INC. 700 SAGINAW DR. REDWOOD CITY CA 94063 true false false false Common Stock 2016-10-29 4 M false 5000.00 5.83 A 5000.00 D Restricted Stock Units 0.00 2016-10-27 4 A false 5000.00 0.00 A 2017-10-27 Common Stock 5000.00 5000.00 D Stock Option (Right to Buy) 5.95 2016-10-27 4 A false 25000.00 0.00 A 2017-10-27 2026-10-27 Common Stock 25000.00 25000.00 D Restricted Stock Units 0.00 2016-10-29 4 M false 5000.00 0.00 D 2016-10-29 Common Stock 5000.00 0.00 D Shares issued upon settlement of Restricted Stock Units ("RSUs") granted by the Issuer on October 29, 2015 as a results of the vesting of all such RSUs. RSUs awarded to the reporting person for no additional cash consideration and represent a contingent right to receive one share of Array BioPharma Inc. common stock. The units vest and will be settled in stock on October 27, 2017, subject to continued service on Array's board of directors. RSUs awarded to the reporting person on October 29, 2015 for no additional cash consideration and represent a contingent right to receive one share of Array BioPharma Inc. common stock. The units vested and were settled in stock on October 29, 2016. John R. Moore, attorney-in-fact for Reporting Person 2016-10-31